• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO S. DE R.L. DE CV HARMONY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO S. DE R.L. DE CV HARMONY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI Back to Search Results
Model Number HARMONY-25
Medical Device Problem Codes Mechanics Altered (2984); Thickening of Material (4056)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 11/14/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported approximately one year, one month, three weeks following the implant of a transcatheter pulmonary bioprosthetic valve, a computed tomography was performed and hypo attenuated leaflet thickening grade iii (50-75%) of the posterior and anterior leaflets was observed with severe reduced leaflet motion (70-99%) indicating hypoattenuation affecting motion.No patient symptoms or treatment were reported.
 
Event or Problem Description
Additional information received indicated that an echocardiogram performed identified a mean gradient of 9 millimeters of mercury (mm hg).The event was treated with concomitant medication, no further intervention reported.
 
Additional Manufacturer Narrative
Updated data: b2, b5, h1, h6 h1: new information supports the update from malfunction to serious injury due to treatment required.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Updated data: b5, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information received indicated that the computed tomography (ct) performed also noted patchy areas of grade 1 (25%) hyperattenuated leaflet thickening (halt) involving the anterior-right and anterior-facing leaflets with no significant reduced leaflet motion (relm).Pannus and paravalvular leak (pvl) were absent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HARMONY TRANSCATHETER PULMONARY VALVE
Common Device Name
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI
Manufacturer (Section D)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key23789323
Report Number9617601-2025-03420
Device Sequence Number10453609
Product Code NPV
UDI-Device Identifier00763000338992
UDI-Public(01)00763000338992(17)241129
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P200046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/22/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/29/2024
Device Model NumberHARMONY-25
Device Catalogue NumberHARMONY-25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/20/2025
Supplement Date Received by Manufacturer12/12/2025
03/25/2026
Initial Report FDA Received Date12/12/2025
Supplement Report FDA Received Date01/07/2026
04/22/2026
Date Device Manufactured11/30/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NO
Outcome Attributed to Adverse Event Required Intervention;
Patient Age63 YR
Patient SexMale
Patient Weight92 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-